

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit biogenesis (GO:0042274) | 6.04959932 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.87490455 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.73743763 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.43058073 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.38615917 |
| 6 | vocalization behavior (GO:0071625) | 5.35560386 |
| 7 | viral transcription (GO:0019083) | 5.26497685 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.25577770 |
| 9 | glutamate secretion (GO:0014047) | 5.21933905 |
| 10 | synaptic vesicle maturation (GO:0016188) | 5.16820435 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.13973970 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.05053101 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.89185721 |
| 14 | translational termination (GO:0006415) | 4.88786499 |
| 15 | protein localization to synapse (GO:0035418) | 4.83244543 |
| 16 | locomotory exploration behavior (GO:0035641) | 4.83236446 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.66704719 |
| 18 | maturation of SSU-rRNA (GO:0030490) | 4.63801849 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.61845752 |
| 20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.56578847 |
| 21 | neuronal action potential propagation (GO:0019227) | 4.46903195 |
| 22 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.42332036 |
| 23 | translational elongation (GO:0006414) | 4.35365798 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.21598719 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 4.20860563 |
| 26 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.20268378 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.18017804 |
| 28 | neurotransmitter secretion (GO:0007269) | 4.16873905 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.14972790 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 4.14710596 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 4.11200102 |
| 32 | ribosomal small subunit assembly (GO:0000028) | 4.09719738 |
| 33 | viral life cycle (GO:0019058) | 4.05087060 |
| 34 | exploration behavior (GO:0035640) | 3.99615901 |
| 35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.98966205 |
| 36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.97457191 |
| 37 | cellular protein complex disassembly (GO:0043624) | 3.97317780 |
| 38 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.94166359 |
| 39 | regulation of synapse structural plasticity (GO:0051823) | 3.90958734 |
| 40 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.90602985 |
| 41 | protein targeting to ER (GO:0045047) | 3.90064298 |
| 42 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.89386372 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.86197333 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.85760151 |
| 45 | cotranslational protein targeting to membrane (GO:0006613) | 3.81715386 |
| 46 | positive regulation of synapse maturation (GO:0090129) | 3.80237899 |
| 47 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.79239051 |
| 48 | protein complex disassembly (GO:0043241) | 3.75930169 |
| 49 | regulation of postsynaptic membrane potential (GO:0060078) | 3.74787404 |
| 50 | NADH metabolic process (GO:0006734) | 3.73931223 |
| 51 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.71511268 |
| 52 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.68214066 |
| 53 | protein localization to endoplasmic reticulum (GO:0070972) | 3.67039223 |
| 54 | regulation of translational fidelity (GO:0006450) | 3.66423646 |
| 55 | regulation of synaptic plasticity (GO:0048167) | 3.66241394 |
| 56 | synaptic vesicle endocytosis (GO:0048488) | 3.65078697 |
| 57 | positive regulation of membrane potential (GO:0045838) | 3.62269584 |
| 58 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.61062939 |
| 59 | translational initiation (GO:0006413) | 3.59231513 |
| 60 | long-term memory (GO:0007616) | 3.51274308 |
| 61 | macromolecular complex disassembly (GO:0032984) | 3.50286603 |
| 62 | regulation of neurotransmitter secretion (GO:0046928) | 3.50006617 |
| 63 | neuron recognition (GO:0008038) | 3.49405916 |
| 64 | presynaptic membrane assembly (GO:0097105) | 3.47637142 |
| 65 | proline transport (GO:0015824) | 3.46025241 |
| 66 | postsynaptic membrane organization (GO:0001941) | 3.43517813 |
| 67 | maternal placenta development (GO:0001893) | 3.39700075 |
| 68 | positive regulation of neurotransmitter transport (GO:0051590) | 3.39517809 |
| 69 | response to histamine (GO:0034776) | 3.39022681 |
| 70 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 3.38721045 |
| 71 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 3.38721045 |
| 72 | cellular potassium ion homeostasis (GO:0030007) | 3.38720980 |
| 73 | regulation of glutamate secretion (GO:0014048) | 3.38619760 |
| 74 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.38368575 |
| 75 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.38331567 |
| 76 | activation of protein kinase A activity (GO:0034199) | 3.38047057 |
| 77 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.36448054 |
| 78 | regulation of vesicle fusion (GO:0031338) | 3.35464380 |
| 79 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33865679 |
| 80 | neurotransmitter transport (GO:0006836) | 3.31858673 |
| 81 | COPI coating of Golgi vesicle (GO:0048205) | 3.31602385 |
| 82 | Golgi transport vesicle coating (GO:0048200) | 3.31602385 |
| 83 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.30039100 |
| 84 | presynaptic membrane organization (GO:0097090) | 3.29871453 |
| 85 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.29804604 |
| 86 | DNA unwinding involved in DNA replication (GO:0006268) | 3.28164558 |
| 87 | protein complex localization (GO:0031503) | 3.24982469 |
| 88 | membrane depolarization (GO:0051899) | 3.23590057 |
| 89 | negative regulation of microtubule polymerization (GO:0031115) | 3.23407997 |
| 90 | regulation of water loss via skin (GO:0033561) | 3.22701332 |
| 91 | axonal fasciculation (GO:0007413) | 3.22192512 |
| 92 | behavioral defense response (GO:0002209) | 3.22023151 |
| 93 | behavioral fear response (GO:0001662) | 3.22023151 |
| 94 | layer formation in cerebral cortex (GO:0021819) | 3.19576668 |
| 95 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.18371904 |
| 96 | regulation of neurotransmitter transport (GO:0051588) | 3.18029985 |
| 97 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.17517040 |
| 98 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 3.15678681 |
| 99 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.15416966 |
| 100 | sodium ion export (GO:0071436) | 3.15381215 |
| 101 | vesicle transport along microtubule (GO:0047496) | 3.15341410 |
| 102 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.15126684 |
| 103 | membrane depolarization during action potential (GO:0086010) | 3.14857689 |
| 104 | dendritic spine morphogenesis (GO:0060997) | 3.13258224 |
| 105 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.13252306 |
| 106 | regulation of chromatin binding (GO:0035561) | 3.09347584 |
| 107 | cerebellar granule cell differentiation (GO:0021707) | 3.08655878 |
| 108 | positive regulation of synaptic transmission (GO:0050806) | 3.08481546 |
| 109 | proline biosynthetic process (GO:0006561) | 3.08167174 |
| 110 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.07311423 |
| 111 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.07311423 |
| 112 | regulation of neurotransmitter levels (GO:0001505) | 3.07232680 |
| 113 | transferrin transport (GO:0033572) | 3.07204210 |
| 114 | protein targeting to membrane (GO:0006612) | 3.05233276 |
| 115 | fear response (GO:0042596) | 3.04442472 |
| 116 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.03235187 |
| 117 | negative regulation of dendrite development (GO:2000171) | 3.02983043 |
| 118 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.02649745 |
| 119 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.01828586 |
| 120 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.01543689 |
| 121 | regulation of synapse maturation (GO:0090128) | 3.00844940 |
| 122 | negative regulation of amino acid transport (GO:0051956) | 3.00557858 |
| 123 | regulation of synaptic transmission (GO:0050804) | 2.99216496 |
| 124 | detection of calcium ion (GO:0005513) | 2.99211730 |
| 125 | regulation of dendritic spine development (GO:0060998) | 2.99126690 |
| 126 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.98240181 |
| 127 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.97650128 |
| 128 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.97231391 |
| 129 | synaptic transmission (GO:0007268) | 2.96920013 |
| 130 | mitotic chromosome condensation (GO:0007076) | 2.96013154 |
| 131 | gamma-aminobutyric acid transport (GO:0015812) | 2.95938888 |
| 132 | learning (GO:0007612) | 2.95121405 |
| 133 | behavioral response to cocaine (GO:0048148) | 2.94685775 |
| 134 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.92238823 |
| 135 | transmission of nerve impulse (GO:0019226) | 2.90139850 |
| 136 | innervation (GO:0060384) | 2.89430350 |
| 137 | neuromuscular process controlling balance (GO:0050885) | 2.85374828 |
| 138 | synaptic vesicle transport (GO:0048489) | 2.85145176 |
| 139 | establishment of synaptic vesicle localization (GO:0097480) | 2.85145176 |
| 140 | long term synaptic depression (GO:0060292) | 2.84620719 |
| 141 | ferric iron transport (GO:0015682) | 2.83838686 |
| 142 | trivalent inorganic cation transport (GO:0072512) | 2.83838686 |
| 143 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.83806768 |
| 144 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.83587153 |
| 145 | ear development (GO:0043583) | 2.82468763 |
| 146 | protein retention in ER lumen (GO:0006621) | 2.79967661 |
| 147 | mitochondrial fusion (GO:0008053) | 2.78986502 |
| 148 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.75139285 |
| 149 | focal adhesion assembly (GO:0048041) | 2.74230697 |
| 150 | cell-substrate adherens junction assembly (GO:0007045) | 2.74230697 |
| 151 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.72816174 |
| 152 | cellular protein complex localization (GO:0034629) | 2.72202352 |
| 153 | negative regulation of cell size (GO:0045792) | 2.70924708 |
| 154 | dopamine receptor signaling pathway (GO:0007212) | 2.69280926 |
| 155 | response to parathyroid hormone (GO:0071107) | 2.68360115 |
| 156 | adherens junction assembly (GO:0034333) | 2.67473399 |
| 157 | nucleosome disassembly (GO:0006337) | 2.67398543 |
| 158 | protein-DNA complex disassembly (GO:0032986) | 2.67398543 |
| 159 | formation of translation preinitiation complex (GO:0001731) | 2.66652667 |
| 160 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.65656242 |
| 161 | regulation of early endosome to late endosome transport (GO:2000641) | 2.62234257 |
| 162 | adenine nucleotide transport (GO:0051503) | 2.61716628 |
| 163 | histone arginine methylation (GO:0034969) | 2.61074527 |
| 164 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.59322494 |
| 165 | negative regulation of organelle assembly (GO:1902116) | 2.58694139 |
| 166 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.57793408 |
| 167 | UTP metabolic process (GO:0046051) | 2.56782133 |
| 168 | establishment of protein localization to membrane (GO:0090150) | 2.55082518 |
| 169 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.54702074 |
| 170 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.52079707 |
| 171 | RNA stabilization (GO:0043489) | 2.51700502 |
| 172 | mRNA stabilization (GO:0048255) | 2.51700502 |
| 173 | pentose-phosphate shunt (GO:0006098) | 2.50979032 |
| 174 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.49696815 |
| 175 | mRNA catabolic process (GO:0006402) | 2.48551069 |
| 176 | translation (GO:0006412) | 2.48077980 |
| 177 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.47417897 |
| 178 | activation of Rac GTPase activity (GO:0032863) | 2.47008903 |
| 179 | nuclear envelope reassembly (GO:0031468) | 2.46563235 |
| 180 | mitotic nuclear envelope reassembly (GO:0007084) | 2.46563235 |
| 181 | purine nucleotide transport (GO:0015865) | 2.45730345 |
| 182 | trophectodermal cell differentiation (GO:0001829) | 2.45510290 |
| 183 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.45253998 |
| 184 | multicellular organismal water homeostasis (GO:0050891) | 2.45072042 |
| 185 | positive regulation of mitochondrion organization (GO:0010822) | 2.43547995 |
| 186 | G1 DNA damage checkpoint (GO:0044783) | 2.41605691 |
| 187 | establishment of skin barrier (GO:0061436) | 2.41018678 |
| 188 | gluconeogenesis (GO:0006094) | 2.40614956 |
| 189 | protein insertion into membrane (GO:0051205) | 2.39944937 |
| 190 | monosaccharide biosynthetic process (GO:0046364) | 2.39358836 |
| 191 | UTP biosynthetic process (GO:0006228) | 2.38285317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.08021821 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.98929580 |
| 3 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.46405384 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.31500304 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.19273377 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.09819265 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04891346 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.80602439 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.80417661 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.75155230 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74245301 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.73118326 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.73118326 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.70556101 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63390917 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.60929300 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.59177010 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51315713 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.50637958 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.44634647 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.43019326 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40722401 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.36686493 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.35081371 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30698579 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.30617846 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.30088466 |
| 28 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.25018605 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21249810 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.17231461 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.16275936 |
| 32 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.15091784 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13665629 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13485450 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11042307 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.09719780 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.07991806 |
| 38 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.06581953 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.04365228 |
| 40 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.01207037 |
| 41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.01018607 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.99072608 |
| 43 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.96662410 |
| 44 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.94018658 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87740566 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87137347 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.84992050 |
| 48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.83767418 |
| 49 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.81738921 |
| 50 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.81253783 |
| 51 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.80800996 |
| 52 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.75974186 |
| 53 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.73467176 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72316245 |
| 55 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.68063253 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67951840 |
| 57 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64495718 |
| 58 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.64049228 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63836770 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63627219 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.62464540 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.61865776 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60376112 |
| 64 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59100173 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.57765026 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.56806794 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56019706 |
| 68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53658427 |
| 69 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.53044372 |
| 70 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.51934923 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51283157 |
| 72 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.50928649 |
| 73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.49153541 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48554478 |
| 75 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.47056106 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45893660 |
| 77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44689495 |
| 78 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43812559 |
| 79 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42925847 |
| 80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42386767 |
| 81 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.42347321 |
| 82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42201247 |
| 83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41834547 |
| 84 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41759272 |
| 85 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.40838759 |
| 86 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40589030 |
| 87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40269681 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39403533 |
| 89 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.39124283 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38692628 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.35397459 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35321445 |
| 93 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.35077743 |
| 94 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34938707 |
| 95 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.34155342 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.34004799 |
| 97 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32655492 |
| 98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32553512 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32463769 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.31124068 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.30780936 |
| 102 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30170735 |
| 103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.29453930 |
| 104 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27914467 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.27564977 |
| 106 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.26968903 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26955306 |
| 108 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25714977 |
| 109 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25453637 |
| 110 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24768696 |
| 111 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24346374 |
| 112 | * PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.23241092 |
| 113 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22836908 |
| 114 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22770137 |
| 115 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22476553 |
| 116 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22150948 |
| 117 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22087504 |
| 118 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.21440369 |
| 119 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20454212 |
| 120 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20128732 |
| 121 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19903095 |
| 122 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.18794562 |
| 123 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18666277 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.18563051 |
| 125 | AR_19668381_ChIP-Seq_PC3_Human | 1.18232206 |
| 126 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.18011867 |
| 127 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17628176 |
| 128 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.17542006 |
| 129 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17356642 |
| 130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17173465 |
| 131 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16954668 |
| 132 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.16494758 |
| 133 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14730717 |
| 134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14256680 |
| 135 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13874293 |
| 136 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.13474288 |
| 137 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12697472 |
| 138 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12458173 |
| 139 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11998977 |
| 140 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11545398 |
| 141 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11477751 |
| 142 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11115144 |
| 143 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10064034 |
| 144 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09820214 |
| 145 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09636645 |
| 146 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09535387 |
| 147 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09479319 |
| 148 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.09147698 |
| 149 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08860169 |
| 150 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08631489 |
| 151 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08309803 |
| 152 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07104734 |
| 153 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06322283 |
| 154 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06264453 |
| 155 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06256199 |
| 156 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05106119 |
| 157 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04619808 |
| 158 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04590169 |
| 159 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04306160 |
| 160 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03618758 |
| 161 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.03266850 |
| 162 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03059874 |
| 163 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03005899 |
| 164 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02860113 |
| 165 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02844426 |
| 166 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02697315 |
| 167 | JUN_21703547_ChIP-Seq_K562_Human | 1.02653552 |
| 168 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.02012736 |
| 169 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01843314 |
| 170 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00986752 |
| 171 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.00930853 |
| 172 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99819358 |
| 173 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98728933 |
| 174 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97637052 |
| 175 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96882272 |
| 176 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96553459 |
| 177 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96247163 |
| 178 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96194707 |
| 179 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93774157 |
| 180 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92317617 |
| 181 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.91351644 |
| 182 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91039076 |
| 183 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.90593696 |
| 184 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90592647 |
| 185 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90044361 |
| 186 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88945837 |
| 187 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88589758 |
| 188 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86496720 |
| 189 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85885386 |
| 190 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85237439 |
| 191 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83888929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.47058925 |
| 2 | MP0003880_abnormal_central_pattern | 5.51863526 |
| 3 | MP0009379_abnormal_foot_pigmentation | 4.61104968 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.17853159 |
| 5 | MP0009745_abnormal_behavioral_response | 3.50061459 |
| 6 | MP0002796_impaired_skin_barrier | 3.47352958 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.41587874 |
| 8 | MP0004270_analgesia | 3.40781831 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.37684206 |
| 10 | MP0002064_seizures | 3.26805898 |
| 11 | MP0009046_muscle_twitch | 3.13180894 |
| 12 | MP0002736_abnormal_nociception_after | 2.94421208 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.85082053 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.83162769 |
| 15 | MP0002272_abnormal_nervous_system | 2.51061503 |
| 16 | MP0003693_abnormal_embryo_hatching | 2.47964509 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.44160166 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.42446185 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.42153336 |
| 20 | MP0002822_catalepsy | 2.31262953 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.25179913 |
| 22 | MP0005501_abnormal_skin_physiology | 2.20397550 |
| 23 | MP0001486_abnormal_startle_reflex | 2.19734549 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.17158695 |
| 25 | MP0001346_abnormal_lacrimal_gland | 2.02864581 |
| 26 | MP0002067_abnormal_sensory_capabilities | 2.02487899 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.98311819 |
| 28 | MP0009672_abnormal_birth_weight | 1.96349432 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.96015733 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.95043580 |
| 31 | MP0001970_abnormal_pain_threshold | 1.92278604 |
| 32 | MP0005451_abnormal_body_composition | 1.92270194 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.91029827 |
| 34 | MP0003787_abnormal_imprinting | 1.90074872 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.89756399 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.83952681 |
| 37 | MP0000751_myopathy | 1.80980653 |
| 38 | MP0003329_amyloid_beta_deposits | 1.78908604 |
| 39 | MP0008569_lethality_at_weaning | 1.76215881 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.74029419 |
| 41 | MP0004858_abnormal_nervous_system | 1.73120641 |
| 42 | MP0004924_abnormal_behavior | 1.73022509 |
| 43 | MP0005386_behavior/neurological_phenoty | 1.73022509 |
| 44 | MP0004811_abnormal_neuron_physiology | 1.72717259 |
| 45 | MP0003879_abnormal_hair_cell | 1.69282185 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.68766357 |
| 47 | MP0002184_abnormal_innervation | 1.66739412 |
| 48 | MP0004957_abnormal_blastocyst_morpholog | 1.65516303 |
| 49 | MP0003111_abnormal_nucleus_morphology | 1.63853798 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.58269238 |
| 51 | MP0000778_abnormal_nervous_system | 1.56791565 |
| 52 | MP0000678_abnormal_parathyroid_gland | 1.53863173 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.51254251 |
| 54 | MP0000750_abnormal_muscle_regeneration | 1.50558561 |
| 55 | MP0000579_abnormal_nail_morphology | 1.49601697 |
| 56 | MP0003122_maternal_imprinting | 1.45394670 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.44396619 |
| 58 | MP0001984_abnormal_olfaction | 1.43629769 |
| 59 | MP0000566_synostosis | 1.36467422 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.36281536 |
| 61 | MP0002066_abnormal_motor_capabilities/c | 1.34575273 |
| 62 | MP0003633_abnormal_nervous_system | 1.30871179 |
| 63 | MP0001730_embryonic_growth_arrest | 1.30627737 |
| 64 | MP0002098_abnormal_vibrissa_morphology | 1.29805813 |
| 65 | MP0000955_abnormal_spinal_cord | 1.29723170 |
| 66 | MP0003941_abnormal_skin_development | 1.29255212 |
| 67 | MP0001905_abnormal_dopamine_level | 1.28696774 |
| 68 | MP0002882_abnormal_neuron_morphology | 1.27722313 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 1.26869557 |
| 70 | MP0005058_abnormal_lysosome_morphology | 1.24592324 |
| 71 | MP0001529_abnormal_vocalization | 1.23283862 |
| 72 | MP0010094_abnormal_chromosome_stability | 1.22844963 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 1.21939571 |
| 74 | MP0000350_abnormal_cell_proliferation | 1.21729002 |
| 75 | MP0001502_abnormal_circadian_rhythm | 1.21659232 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 1.17948685 |
| 77 | MP0000013_abnormal_adipose_tissue | 1.16905063 |
| 78 | MP0002249_abnormal_larynx_morphology | 1.16493267 |
| 79 | MP0001188_hyperpigmentation | 1.15439134 |
| 80 | MP0003077_abnormal_cell_cycle | 1.14742720 |
| 81 | MP0004087_abnormal_muscle_fiber | 1.13993070 |
| 82 | MP0001727_abnormal_embryo_implantation | 1.11140582 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 1.10770194 |
| 84 | MP0004215_abnormal_myocardial_fiber | 1.10647636 |
| 85 | MP0001881_abnormal_mammary_gland | 1.09954582 |
| 86 | MP0000627_abnormal_mammary_gland | 1.09029901 |
| 87 | MP0010386_abnormal_urinary_bladder | 1.08231954 |
| 88 | MP0003631_nervous_system_phenotype | 1.08037385 |
| 89 | MP0004233_abnormal_muscle_weight | 1.07577601 |
| 90 | MP0004142_abnormal_muscle_tone | 1.06226450 |
| 91 | MP0004484_altered_response_of | 1.06101886 |
| 92 | MP0003646_muscle_fatigue | 1.06046562 |
| 93 | MP0002080_prenatal_lethality | 1.03682997 |
| 94 | MP0005645_abnormal_hypothalamus_physiol | 1.02460750 |
| 95 | MP0000537_abnormal_urethra_morphology | 1.01329660 |
| 96 | MP0008874_decreased_physiological_sensi | 0.98212418 |
| 97 | MP0004510_myositis | 0.97996079 |
| 98 | MP0008932_abnormal_embryonic_tissue | 0.96618139 |
| 99 | MP0002089_abnormal_postnatal_growth/wei | 0.96359367 |
| 100 | MP0008872_abnormal_physiological_respon | 0.96329357 |
| 101 | MP0003938_abnormal_ear_development | 0.96071720 |
| 102 | MP0005083_abnormal_biliary_tract | 0.94817621 |
| 103 | MP0004885_abnormal_endolymph | 0.94505182 |
| 104 | MP0000604_amyloidosis | 0.94186529 |
| 105 | MP0000377_abnormal_hair_follicle | 0.94118952 |
| 106 | MP0001849_ear_inflammation | 0.92167956 |
| 107 | MP0002152_abnormal_brain_morphology | 0.92084672 |
| 108 | MP0000733_abnormal_muscle_development | 0.88200590 |
| 109 | MP0006035_abnormal_mitochondrial_morpho | 0.86532547 |
| 110 | MP0004085_abnormal_heartbeat | 0.86089155 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.85820127 |
| 112 | MP0003075_altered_response_to | 0.85706882 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.85233562 |
| 114 | MP0010630_abnormal_cardiac_muscle | 0.84875770 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.84700708 |
| 116 | MP0005380_embryogenesis_phenotype | 0.83921865 |
| 117 | MP0001672_abnormal_embryogenesis/_devel | 0.83921865 |
| 118 | MP0004036_abnormal_muscle_relaxation | 0.83513122 |
| 119 | MP0001697_abnormal_embryo_size | 0.82967971 |
| 120 | MP0010234_abnormal_vibrissa_follicle | 0.82308624 |
| 121 | MP0002069_abnormal_eating/drinking_beha | 0.82196590 |
| 122 | MP0001348_abnormal_lacrimal_gland | 0.81874360 |
| 123 | MP0002229_neurodegeneration | 0.81006057 |
| 124 | MP0000462_abnormal_digestive_system | 0.79779357 |
| 125 | MP0008007_abnormal_cellular_replicative | 0.79693904 |
| 126 | MP0002269_muscular_atrophy | 0.78249697 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.78043944 |
| 128 | MP0005535_abnormal_body_temperature | 0.77017753 |
| 129 | MP0003984_embryonic_growth_retardation | 0.76876501 |
| 130 | MP0010678_abnormal_skin_adnexa | 0.76649891 |
| 131 | MP0001919_abnormal_reproductive_system | 0.76523140 |
| 132 | MP0004130_abnormal_muscle_cell | 0.75446975 |
| 133 | MP0002085_abnormal_embryonic_tissue | 0.74646468 |
| 134 | MP0000569_abnormal_digit_pigmentation | 0.74433930 |
| 135 | MP0004381_abnormal_hair_follicle | 0.74178377 |
| 136 | MP0002088_abnormal_embryonic_growth/wei | 0.74157139 |
| 137 | MP0000749_muscle_degeneration | 0.74154518 |
| 138 | MP0001177_atelectasis | 0.73558969 |
| 139 | MP0010771_integument_phenotype | 0.72802905 |
| 140 | MP0009703_decreased_birth_body | 0.71758290 |
| 141 | MP0000313_abnormal_cell_death | 0.71547092 |
| 142 | MP0004147_increased_porphyrin_level | 0.71446442 |
| 143 | MP0009931_abnormal_skin_appearance | 0.70395890 |
| 144 | MP0002090_abnormal_vision | 0.69671410 |
| 145 | MP0005409_darkened_coat_color | 0.69284148 |
| 146 | MP0001963_abnormal_hearing_physiology | 0.69188489 |
| 147 | MP0005623_abnormal_meninges_morphology | 0.67730565 |
| 148 | MP0005620_abnormal_muscle_contractility | 0.67245062 |
| 149 | MP0004742_abnormal_vestibular_system | 0.67023534 |
| 150 | MP0000747_muscle_weakness | 0.64674584 |
| 151 | MP0008961_abnormal_basal_metabolism | 0.64409699 |
| 152 | MP0003634_abnormal_glial_cell | 0.64052281 |
| 153 | MP0003632_abnormal_nervous_system | 0.64008473 |
| 154 | MP0001944_abnormal_pancreas_morphology | 0.63753836 |
| 155 | MP0000490_abnormal_crypts_of | 0.62915630 |
| 156 | MP0003861_abnormal_nervous_system | 0.62458879 |
| 157 | MP0003183_abnormal_peptide_metabolism | 0.61646437 |
| 158 | MP0001664_abnormal_digestion | 0.61480939 |
| 159 | MP0005499_abnormal_olfactory_system | 0.58973788 |
| 160 | MP0005394_taste/olfaction_phenotype | 0.58973788 |
| 161 | MP0001943_abnormal_respiration | 0.58312632 |
| 162 | MP0002752_abnormal_somatic_nervous | 0.56275879 |
| 163 | MP0003137_abnormal_impulse_conducting | 0.55733902 |
| 164 | MP0005167_abnormal_blood-brain_barrier | 0.55341858 |
| 165 | MP0000759_abnormal_skeletal_muscle | 0.51640570 |
| 166 | MP0003690_abnormal_glial_cell | 0.51111394 |
| 167 | MP0002106_abnormal_muscle_physiology | 0.50136339 |
| 168 | MP0003123_paternal_imprinting | 0.49552510 |
| 169 | MP0002972_abnormal_cardiac_muscle | 0.47927382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.21778450 |
| 2 | Myokymia (HP:0002411) | 5.97272762 |
| 3 | Focal seizures (HP:0007359) | 5.78406309 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.33938845 |
| 5 | Visual hallucinations (HP:0002367) | 5.31396230 |
| 6 | Atonic seizures (HP:0010819) | 5.26164590 |
| 7 | Febrile seizures (HP:0002373) | 4.87609447 |
| 8 | Absence seizures (HP:0002121) | 4.57142153 |
| 9 | Dialeptic seizures (HP:0011146) | 4.13062915 |
| 10 | Hyperventilation (HP:0002883) | 4.08001670 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.88465337 |
| 12 | Progressive muscle weakness (HP:0003323) | 3.79774962 |
| 13 | Hyperacusis (HP:0010780) | 3.73786673 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.69226559 |
| 15 | Distal lower limb muscle weakness (HP:0009053) | 3.68171934 |
| 16 | Broad-based gait (HP:0002136) | 3.60684993 |
| 17 | Amblyopia (HP:0000646) | 3.46339713 |
| 18 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.43596128 |
| 19 | Poor eye contact (HP:0000817) | 3.32001638 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.31411847 |
| 21 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.30236664 |
| 22 | Depression (HP:0000716) | 3.10707813 |
| 23 | Myopathic facies (HP:0002058) | 3.08208046 |
| 24 | Action tremor (HP:0002345) | 3.07154800 |
| 25 | Asymmetry of the thorax (HP:0001555) | 3.06677725 |
| 26 | Septate vagina (HP:0001153) | 2.99247837 |
| 27 | Ankle clonus (HP:0011448) | 2.98575542 |
| 28 | Insomnia (HP:0100785) | 2.98251673 |
| 29 | Anxiety (HP:0000739) | 2.96040237 |
| 30 | Abnormal social behavior (HP:0012433) | 2.95507307 |
| 31 | Impaired social interactions (HP:0000735) | 2.95507307 |
| 32 | Abnormality of the lower motor neuron (HP:0002366) | 2.95233449 |
| 33 | Truncal ataxia (HP:0002078) | 2.95052721 |
| 34 | Pheochromocytoma (HP:0002666) | 2.94953894 |
| 35 | Hyperparathyroidism (HP:0000843) | 2.94144090 |
| 36 | Gaze-evoked nystagmus (HP:0000640) | 2.89864569 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 2.87644716 |
| 38 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.81688251 |
| 39 | Abnormal eating behavior (HP:0100738) | 2.80890024 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.78262060 |
| 41 | Distal lower limb amyotrophy (HP:0008944) | 2.76303141 |
| 42 | Abnormal number of erythroid precursors (HP:0012131) | 2.74579034 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.70885452 |
| 44 | Progressive inability to walk (HP:0002505) | 2.64741685 |
| 45 | Dysdiadochokinesis (HP:0002075) | 2.61757622 |
| 46 | Reticulocytopenia (HP:0001896) | 2.61347813 |
| 47 | Excessive salivation (HP:0003781) | 2.60664142 |
| 48 | Drooling (HP:0002307) | 2.60664142 |
| 49 | Ragged-red muscle fibers (HP:0003200) | 2.55008007 |
| 50 | Exercise-induced myalgia (HP:0003738) | 2.48089856 |
| 51 | Urinary urgency (HP:0000012) | 2.47668517 |
| 52 | Shoulder girdle muscle weakness (HP:0003547) | 2.46931858 |
| 53 | Dysmetria (HP:0001310) | 2.46913727 |
| 54 | Dysmetric saccades (HP:0000641) | 2.46443228 |
| 55 | Diplopia (HP:0000651) | 2.45552625 |
| 56 | Abnormality of binocular vision (HP:0011514) | 2.45552625 |
| 57 | Overriding aorta (HP:0002623) | 2.43690488 |
| 58 | Epileptiform EEG discharges (HP:0011182) | 2.43583074 |
| 59 | Muscle fiber inclusion bodies (HP:0100299) | 2.40745742 |
| 60 | Fetal akinesia sequence (HP:0001989) | 2.40372794 |
| 61 | EMG: neuropathic changes (HP:0003445) | 2.40027785 |
| 62 | Abnormality of the salivary glands (HP:0010286) | 2.39049169 |
| 63 | Achilles tendon contracture (HP:0001771) | 2.38867653 |
| 64 | Nemaline bodies (HP:0003798) | 2.38516043 |
| 65 | Bowel incontinence (HP:0002607) | 2.35593868 |
| 66 | Insidious onset (HP:0003587) | 2.35212785 |
| 67 | Termporal pattern (HP:0011008) | 2.35212785 |
| 68 | Obstructive sleep apnea (HP:0002870) | 2.34882426 |
| 69 | Abnormal hair whorl (HP:0010721) | 2.34620251 |
| 70 | Impaired smooth pursuit (HP:0007772) | 2.34174790 |
| 71 | Stereotypic behavior (HP:0000733) | 2.33850918 |
| 72 | Inability to walk (HP:0002540) | 2.33216753 |
| 73 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.33069961 |
| 74 | Macrocytic anemia (HP:0001972) | 2.32170986 |
| 75 | Broad distal phalanx of finger (HP:0009836) | 2.30724192 |
| 76 | Multiple enchondromatosis (HP:0005701) | 2.30581349 |
| 77 | Progressive external ophthalmoplegia (HP:0000590) | 2.29794112 |
| 78 | Foot dorsiflexor weakness (HP:0009027) | 2.29676765 |
| 79 | Gout (HP:0001997) | 2.29654086 |
| 80 | Spinal cord compression (HP:0002176) | 2.28491966 |
| 81 | Postural instability (HP:0002172) | 2.28296178 |
| 82 | J-shaped sella turcica (HP:0002680) | 2.24795027 |
| 83 | Abnormal large intestine physiology (HP:0012700) | 2.24370597 |
| 84 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.23383393 |
| 85 | Failure to thrive in infancy (HP:0001531) | 2.23110518 |
| 86 | Germ cell neoplasia (HP:0100728) | 2.21078256 |
| 87 | Cerebral inclusion bodies (HP:0100314) | 2.19123710 |
| 88 | Cerebral hypomyelination (HP:0006808) | 2.18693055 |
| 89 | Bradykinesia (HP:0002067) | 2.16386920 |
| 90 | Polyphagia (HP:0002591) | 2.16349369 |
| 91 | Neuronal loss in central nervous system (HP:0002529) | 2.16263133 |
| 92 | Hyporeflexia of lower limbs (HP:0002600) | 2.14766735 |
| 93 | EEG with generalized epileptiform discharges (HP:0011198) | 2.14686384 |
| 94 | Abnormality of reticulocytes (HP:0004312) | 2.14616082 |
| 95 | Protruding tongue (HP:0010808) | 2.14352628 |
| 96 | Pseudobulbar signs (HP:0002200) | 2.14269797 |
| 97 | Resting tremor (HP:0002322) | 2.13902668 |
| 98 | Impaired vibratory sensation (HP:0002495) | 2.12367753 |
| 99 | Genetic anticipation (HP:0003743) | 2.09691808 |
| 100 | Hypercortisolism (HP:0001578) | 2.09083708 |
| 101 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.08764373 |
| 102 | Mutism (HP:0002300) | 2.08448415 |
| 103 | Lower limb amyotrophy (HP:0007210) | 2.07878056 |
| 104 | Hypoventilation (HP:0002791) | 2.07418074 |
| 105 | Bundle branch block (HP:0011710) | 2.06492192 |
| 106 | Abnormality of the foot musculature (HP:0001436) | 2.06189528 |
| 107 | Deep palmar crease (HP:0006191) | 2.06100624 |
| 108 | Absent speech (HP:0001344) | 2.05095570 |
| 109 | Oligomenorrhea (HP:0000876) | 2.03225479 |
| 110 | Incomplete penetrance (HP:0003829) | 2.02192413 |
| 111 | Myotonia (HP:0002486) | 2.00377054 |
| 112 | EMG: myopathic abnormalities (HP:0003458) | 1.99540522 |
| 113 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99427055 |
| 114 | Abnormality of the Achilles tendon (HP:0005109) | 1.99364135 |
| 115 | Lower limb muscle weakness (HP:0007340) | 1.98770115 |
| 116 | Elfin facies (HP:0004428) | 1.97414092 |
| 117 | Spastic gait (HP:0002064) | 1.96813565 |
| 118 | Abnormality of nail color (HP:0100643) | 1.96715362 |
| 119 | Hypsarrhythmia (HP:0002521) | 1.96526002 |
| 120 | Psychosis (HP:0000709) | 1.95905072 |
| 121 | Torticollis (HP:0000473) | 1.95338970 |
| 122 | Scanning speech (HP:0002168) | 1.94482420 |
| 123 | Increased intramyocellular lipid droplets (HP:0012240) | 1.94408567 |
| 124 | Back pain (HP:0003418) | 1.94212706 |
| 125 | Pili torti (HP:0003777) | 1.93553136 |
| 126 | Delusions (HP:0000746) | 1.93373109 |
| 127 | Focal dystonia (HP:0004373) | 1.93360611 |
| 128 | Rapidly progressive (HP:0003678) | 1.93289976 |
| 129 | Papilledema (HP:0001085) | 1.93057394 |
| 130 | Reticulocytosis (HP:0001923) | 1.92479999 |
| 131 | Increased muscle lipid content (HP:0009058) | 1.92155914 |
| 132 | Overlapping toe (HP:0001845) | 1.91815513 |
| 133 | Selective tooth agenesis (HP:0001592) | 1.91645570 |
| 134 | Hemiparesis (HP:0001269) | 1.91008787 |
| 135 | Narrow nasal bridge (HP:0000446) | 1.90728030 |
| 136 | Gait imbalance (HP:0002141) | 1.90709331 |
| 137 | Pallor (HP:0000980) | 1.88208845 |
| 138 | Blue irides (HP:0000635) | 1.86968551 |
| 139 | Hypercalcemia (HP:0003072) | 1.85584676 |
| 140 | Truncus arteriosus (HP:0001660) | 1.85260369 |
| 141 | Status epilepticus (HP:0002133) | 1.84792175 |
| 142 | Conjunctival hamartoma (HP:0100780) | 1.84360521 |
| 143 | Generalized myoclonic seizures (HP:0002123) | 1.83176379 |
| 144 | Exercise-induced muscle cramps (HP:0003710) | 1.83065627 |
| 145 | Dysphonia (HP:0001618) | 1.82475446 |
| 146 | Flat acetabular roof (HP:0003180) | 1.82372951 |
| 147 | Abnormality of the corticospinal tract (HP:0002492) | 1.81485087 |
| 148 | Sudden death (HP:0001699) | 1.81167532 |
| 149 | Gait ataxia (HP:0002066) | 1.80286126 |
| 150 | Pointed chin (HP:0000307) | 1.79770980 |
| 151 | External ophthalmoplegia (HP:0000544) | 1.79259987 |
| 152 | Abnormality of salivation (HP:0100755) | 1.79063790 |
| 153 | Multiple lipomas (HP:0001012) | 1.78719851 |
| 154 | Progressive hearing impairment (HP:0001730) | 1.78320402 |
| 155 | Ventricular fibrillation (HP:0001663) | 1.78229201 |
| 156 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.77862618 |
| 157 | Inappropriate behavior (HP:0000719) | 1.77557387 |
| 158 | Sparse lateral eyebrow (HP:0005338) | 1.77533163 |
| 159 | Abnormality of the calf musculature (HP:0001430) | 1.75060953 |
| 160 | Hemiplegia (HP:0002301) | 1.75017284 |
| 161 | Specific learning disability (HP:0001328) | 1.74883763 |
| 162 | Seborrheic dermatitis (HP:0001051) | 1.74279658 |
| 163 | Tetraplegia (HP:0002445) | 1.74200657 |
| 164 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73394981 |
| 165 | Abnormality of the gastric mucosa (HP:0004295) | 1.72293560 |
| 166 | Hypotrichosis (HP:0001006) | 1.71893464 |
| 167 | Myoglobinuria (HP:0002913) | 1.71749515 |
| 168 | Hyperphosphatemia (HP:0002905) | 1.70933056 |
| 169 | Limb dystonia (HP:0002451) | 1.69980783 |
| 170 | Right ventricular cardiomyopathy (HP:0011663) | 1.69470555 |
| 171 | Hyperthyroidism (HP:0000836) | 1.69208707 |
| 172 | Abnormality of the thoracic spine (HP:0100711) | 1.67822823 |
| 173 | Generalized hypotonia (HP:0001290) | 1.67797302 |
| 174 | Trismus (HP:0000211) | 1.67252411 |
| 175 | Congenital primary aphakia (HP:0007707) | 1.66993075 |
| 176 | Apathy (HP:0000741) | 1.64623385 |
| 177 | Rhabdomyolysis (HP:0003201) | 1.63742046 |
| 178 | Fasciculations (HP:0002380) | 1.63708699 |
| 179 | Personality changes (HP:0000751) | 1.63651581 |
| 180 | Patellar dislocation (HP:0002999) | 1.62845499 |
| 181 | Abnormal atrioventricular conduction (HP:0005150) | 1.62774242 |
| 182 | Macroorchidism (HP:0000053) | 1.62452783 |
| 183 | Atrioventricular block (HP:0001678) | 1.62380137 |
| 184 | Neurofibrillary tangles (HP:0002185) | 1.61898531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.60132733 |
| 2 | EPHA4 | 4.65885547 |
| 3 | NTRK3 | 4.41757215 |
| 4 | EEF2K | 3.60744034 |
| 5 | MAP3K12 | 3.42660130 |
| 6 | MAP3K9 | 3.39868237 |
| 7 | MAP3K4 | 3.13676276 |
| 8 | NME2 | 3.04159466 |
| 9 | CASK | 2.99139631 |
| 10 | SMG1 | 2.83660802 |
| 11 | MAP2K7 | 2.83270605 |
| 12 | DAPK2 | 2.81863024 |
| 13 | RIPK4 | 2.77364098 |
| 14 | CDK12 | 2.56756604 |
| 15 | RPS6KB2 | 2.54828488 |
| 16 | SCYL2 | 2.53573734 |
| 17 | MINK1 | 2.52672020 |
| 18 | SIK1 | 2.30343854 |
| 19 | PLK2 | 2.29844131 |
| 20 | DAPK1 | 2.19022061 |
| 21 | MAPKAPK3 | 2.18954030 |
| 22 | KSR2 | 2.18045545 |
| 23 | MAP2K4 | 2.12248004 |
| 24 | EPHA2 | 2.08403577 |
| 25 | ARAF | 2.00112540 |
| 26 | CDK19 | 1.98764891 |
| 27 | ICK | 1.90201559 |
| 28 | PKN2 | 1.87387336 |
| 29 | MARK1 | 1.83666399 |
| 30 | KSR1 | 1.78938573 |
| 31 | PAK6 | 1.76641917 |
| 32 | IRAK3 | 1.72754472 |
| 33 | MAP3K13 | 1.63580490 |
| 34 | VRK2 | 1.60475400 |
| 35 | CAMKK1 | 1.55544346 |
| 36 | PRPF4B | 1.55132355 |
| 37 | GRK5 | 1.50180471 |
| 38 | MAP2K2 | 1.42665909 |
| 39 | NTRK2 | 1.42575676 |
| 40 | PTK2B | 1.42328715 |
| 41 | CDK5 | 1.40729183 |
| 42 | TESK1 | 1.40669319 |
| 43 | NTRK1 | 1.34001376 |
| 44 | CCNB1 | 1.29777918 |
| 45 | MAP3K10 | 1.29723636 |
| 46 | RIPK1 | 1.22375603 |
| 47 | SIK3 | 1.18340817 |
| 48 | PRKD3 | 1.16461240 |
| 49 | FES | 1.13961037 |
| 50 | PRKCG | 1.12869136 |
| 51 | SIK2 | 1.11118070 |
| 52 | MAPK13 | 1.10967119 |
| 53 | CAMKK2 | 1.10559495 |
| 54 | TESK2 | 1.10341810 |
| 55 | BMPR2 | 1.06357776 |
| 56 | NME1 | 1.04157619 |
| 57 | MAP3K2 | 1.02564773 |
| 58 | ERN1 | 1.02479698 |
| 59 | CAMK2A | 0.99194302 |
| 60 | DMPK | 0.99089265 |
| 61 | MTOR | 0.94233174 |
| 62 | STK16 | 0.93841508 |
| 63 | RAF1 | 0.93755555 |
| 64 | NEK1 | 0.91287079 |
| 65 | TTN | 0.90412336 |
| 66 | MARK2 | 0.89591163 |
| 67 | CDC7 | 0.88929138 |
| 68 | LRRK2 | 0.88390321 |
| 69 | TLK1 | 0.88078643 |
| 70 | PNCK | 0.85816302 |
| 71 | FGFR4 | 0.85681016 |
| 72 | SGK2 | 0.85576817 |
| 73 | CDK18 | 0.84965655 |
| 74 | SRPK1 | 0.84728991 |
| 75 | STK38 | 0.84310675 |
| 76 | NEK6 | 0.83431343 |
| 77 | OBSCN | 0.82957082 |
| 78 | SGK494 | 0.82842163 |
| 79 | SGK223 | 0.82842163 |
| 80 | PHKG1 | 0.79579617 |
| 81 | PHKG2 | 0.79579617 |
| 82 | CDK14 | 0.78699983 |
| 83 | LMTK2 | 0.78440121 |
| 84 | CDK15 | 0.78193589 |
| 85 | FGR | 0.74555193 |
| 86 | FER | 0.74097005 |
| 87 | CAMK2B | 0.73168307 |
| 88 | EIF2AK1 | 0.72966636 |
| 89 | OXSR1 | 0.72017974 |
| 90 | PRKCH | 0.71998146 |
| 91 | PTK6 | 0.70268518 |
| 92 | DAPK3 | 0.70007976 |
| 93 | UHMK1 | 0.69778579 |
| 94 | RET | 0.69237592 |
| 95 | AKT2 | 0.68444756 |
| 96 | MAP2K1 | 0.68155642 |
| 97 | CAMK1 | 0.68038908 |
| 98 | RPS6KB1 | 0.67870147 |
| 99 | ILK | 0.66936864 |
| 100 | CDK11A | 0.66283296 |
| 101 | CDK7 | 0.65228400 |
| 102 | MAP3K11 | 0.65171857 |
| 103 | SGK1 | 0.64789764 |
| 104 | TNIK | 0.63057761 |
| 105 | SGK3 | 0.62662929 |
| 106 | PAK4 | 0.62612037 |
| 107 | MAP3K1 | 0.62029712 |
| 108 | BRAF | 0.61002121 |
| 109 | AURKA | 0.60249074 |
| 110 | PDK1 | 0.59514522 |
| 111 | PDK3 | 0.58893363 |
| 112 | PDK4 | 0.58893363 |
| 113 | PBK | 0.57300101 |
| 114 | PDPK1 | 0.55389724 |
| 115 | GRK7 | 0.54445539 |
| 116 | TTK | 0.53958621 |
| 117 | PRKCE | 0.53734330 |
| 118 | LIMK1 | 0.53062908 |
| 119 | TAOK2 | 0.51730801 |
| 120 | BRSK1 | 0.51640731 |
| 121 | PINK1 | 0.51270218 |
| 122 | TYRO3 | 0.50632241 |
| 123 | STK11 | 0.50496923 |
| 124 | DYRK1A | 0.50052796 |
| 125 | IRAK2 | 0.49774675 |
| 126 | AKT3 | 0.49421787 |
| 127 | BRD4 | 0.49353265 |
| 128 | PAK3 | 0.47028917 |
| 129 | CSNK1E | 0.46956400 |
| 130 | TNK2 | 0.45284680 |
| 131 | GRK6 | 0.44301516 |
| 132 | MAPK12 | 0.44292522 |
| 133 | BUB1 | 0.43610898 |
| 134 | CDK2 | 0.42716125 |
| 135 | ADRBK1 | 0.42178384 |
| 136 | MYLK | 0.42100971 |
| 137 | DYRK3 | 0.41821938 |
| 138 | CDK4 | 0.41040046 |
| 139 | MAPK10 | 0.40492685 |
| 140 | LATS2 | 0.40188271 |
| 141 | AURKB | 0.40040029 |
| 142 | CHEK1 | 0.38777493 |
| 143 | CHEK2 | 0.38061338 |
| 144 | CAMK1D | 0.37623367 |
| 145 | CAMK2D | 0.37356699 |
| 146 | CAMK4 | 0.37233009 |
| 147 | HIPK2 | 0.37140276 |
| 148 | BCR | 0.36940347 |
| 149 | MAPK11 | 0.36632722 |
| 150 | CDK1 | 0.36526140 |
| 151 | PRKCI | 0.36096680 |
| 152 | RPS6KA3 | 0.35993688 |
| 153 | RPS6KA2 | 0.35794496 |
| 154 | ROCK2 | 0.35785744 |
| 155 | TAOK1 | 0.35303637 |
| 156 | FYN | 0.34584819 |
| 157 | ERBB3 | 0.34189803 |
| 158 | CAMK2G | 0.32360680 |
| 159 | MOS | 0.31435702 |
| 160 | PRKCZ | 0.30418795 |
| 161 | ALK | 0.30168998 |
| 162 | MAP3K7 | 0.29880674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.87846672 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.61479145 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.58646187 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.77308321 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.68282384 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63617108 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.61803229 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.40808753 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.39154327 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.37217895 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.36020490 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28658829 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.11460343 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09335497 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.05389688 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02521510 |
| 17 | Thyroid cancer_Homo sapiens_hsa05216 | 1.95575384 |
| 18 | DNA replication_Homo sapiens_hsa03030 | 1.83049227 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80570761 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.79736223 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.74892837 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.74866815 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.71647703 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71441530 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.67309983 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.64889220 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61828542 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57669933 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.56333455 |
| 30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.51757184 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49911722 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.48320598 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.45761389 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45001859 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43923191 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40633407 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39361042 |
| 38 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.35307435 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31547131 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29166861 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28603682 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27571138 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27390385 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26599812 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25285335 |
| 46 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.24201906 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23907548 |
| 48 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.23896316 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.22886207 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19274612 |
| 51 | Glioma_Homo sapiens_hsa05214 | 1.16958322 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.16363512 |
| 53 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15856769 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15082158 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13235253 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.12095827 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.12086323 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.10955285 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.07346433 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 1.06211563 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06112669 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05983637 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03999719 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99201902 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97483113 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97435731 |
| 67 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.95789425 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95725975 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95526854 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95081543 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92192278 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92036668 |
| 73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91313411 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91032624 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.90893171 |
| 76 | Axon guidance_Homo sapiens_hsa04360 | 0.90475109 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90012074 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86500365 |
| 79 | Base excision repair_Homo sapiens_hsa03410 | 0.86359436 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82100287 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.79921875 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79546092 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.78314884 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77647909 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76591815 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74480776 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74306728 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73422485 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72992443 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72884505 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72022628 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71870279 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70825206 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70340381 |
| 95 | Parkinsons disease_Homo sapiens_hsa05012 | 0.67814892 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65305835 |
| 97 | RNA polymerase_Homo sapiens_hsa03020 | 0.65158630 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64976364 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62370030 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61855484 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61477273 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60802005 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59962589 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58639376 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58585838 |
| 106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58556601 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56158443 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53567586 |
| 109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53106969 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.52651447 |
| 111 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.52625618 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52496251 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52495391 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51782681 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51355043 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49967395 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49659955 |
| 118 | Cell cycle_Homo sapiens_hsa04110 | 0.49302771 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49243369 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48234171 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.48228956 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48024007 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47468696 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46703390 |
| 125 | Alcoholism_Homo sapiens_hsa05034 | 0.46458591 |
| 126 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45610928 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45438840 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44967252 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44713361 |
| 130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44382427 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.44292961 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43520967 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.42817478 |
| 134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41662607 |
| 135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40729103 |
| 136 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40471934 |
| 137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39985723 |
| 138 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39366722 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37148268 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37146051 |
| 141 | Tuberculosis_Homo sapiens_hsa05152 | 0.36877540 |
| 142 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35412861 |
| 143 | Salmonella infection_Homo sapiens_hsa05132 | 0.34603187 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.32509268 |
| 145 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.31819993 |
| 146 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.29425905 |
| 147 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28116835 |

